Aurinia Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio223.53
Forward P/E24.06
P/S Ratio5.477.364.5865.0334.93
P/B Ratio3.413.421.516.194.29
Price/Tangible Book3.453.461.546.304.39
Price/FCF29.15
Price/OCF28.97
Enterprise Value Ratios
EV/Revenue4.365.971.8458.9427.27
EV/EBITDA32.08
EV/EBIT81.91
EV/FCF23.25
Profitability & Returns
Return on Equity (ROE)0.02%-0.20%-0.24%-0.41%-0.29%
Return on Assets (ROA)0.01%-0.11%-0.14%-0.22%-0.17%
Return on Invested Capital (ROIC)0.09%-1.15%-4.82%-9.07%-11.09%
Return on Capital Employed (ROCE)0.03%-0.18%-0.26%-0.36%-0.24%
Leverage & Solvency Ratios
Debt/Equity0.210.260.020.020.02
Debt/EBITDA2.42
Debt/FCF1.80
Liquidity Ratios
Current Ratio4.575.509.6012.6313.11
Quick Ratio4.054.868.7611.8412.45
Efficiency Ratios
Asset Turnover0.430.340.260.090.13
Inventory Turnover1.241.982.303.14
Yield & Distribution Ratios
Earnings Yield0.00%-0.06%-0.18%-0.06%-0.06%
FCF Yield0.03%-0.03%-0.13%-0.05%-0.04%
Buyback Yield-0.02%-0.01%-0.10%-0.09%-0.27%